Report : Asia Pacific Pulmonary Devices Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type (Therapeutic Devices, Consumables and Accessories, Diagnostic Devices, and Monitoring Devices); Application (Chronic Obstructive Pulmonary Disease (COPD), Sleep Apnea, Asthma, Infectious Diseases, and Others); and End User (Hospitals, Homecare Settings, and Ambulatory Care Centers) and country
Therapeutics Segment Held Largest Share of Pulmonary Devices Market in 2019
According to our new market research study on "Asia Pacific Pulmonary Devices Market to 2027 – Regional Analysis and Forecast – by Type, Application and End User" the market is expected to reach US$ 8,196.82 million by 2027 from US$ 3,661.53 million in 2019; it is estimated to grow at a CAGR of 10.6% from 2020 to 2027. The report provides trends prevailing in the Asia Pacific pulmonary devices market and the factors driving the market growth along with those hindering it.
In 2019, the therapeutic devices held the largest share in the market and are forecasted to retain its dominance till 2027. The multi-modal and multi-functional use of therapeutic devices for a wide range of pulmonary diseases is expected to account for the growth of the therapeutic de vices segment over the coming years. On the other hand, consumables and accessories is expected to witness fastest growth rate owing to the increasing trend for stockpiling of facial disposable masks to avoid viral transmission.
The growth of the Asia Pacific pulmonary devices market is mainly attributed as increasing incidence of respiratory diseases and growing number of COVID-19 patients in the country. However, the unfavorable reimbursement scenario associated with the pulmonary devices is the major factor hindering the market growth in Asia Pacific.
The Report Segments Asia Pacific Pulmonary devices Market as Follows:
Asia Pacific Pulmonary devices Market – By Type
Asia Pacific Pulmonary devices Market – By Application
Asia Pacific Pulmonary devices Market – By Country